Hyperrab 300 unit/ML vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1P13
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,669
Award facts
- Contract value 100% obligated
- $8,668.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,668.70 delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vial 5mL on December 12, 2025, with an ultimate completion date of January 6, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency and other government healthcare systems. The company holds a significant portfolio of competitively awarded contracts with the DLA Medical Supply Chain, demonstrating its capability to fulfill federal medical supply requirements. The DLA Troop Support Medical IDC enables AmerisourceBergen to provide specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F1P13?
SPE2DR26F1P13 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F1P13 worth?
The government has obligated $8,669 on SPE2DR26F1P13.
Is contract SPE2DR26F1P13 an order under another contract?
Yes. SPE2DR26F1P13 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1P13 competed?
The extent of competition for SPE2DR26F1P13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award